Laurus Labs Limited is a leading research-driven pharmaceutical and biotechnology company specializing in active pharmaceutical ingredients (APIs), finished dosage formulations (FDFs), contract development and manufacturing (CDMO), biotechnology products, and specialty ingredients. Established in 2005, the company has become a significant global supplier of antiretroviral, oncology, cardiovascular, diabetes, and hepatitis medicines while expanding into biologics and advanced therapeutics. Laurus Labs serves customers across more than 80 countries through an integrated manufacturing platform that combines research, process development, API production, formulation manufacturing, and contract services. The company operates world-class manufacturing facilities approved by major international regulatory agencies, enabling exports to regulated and emerging markets. Laurus continues to invest in innovation, biotechnology, fermentation technologies, and sustainable manufacturing to support long-term growth. Through scientific excellence, operational efficiency, and strategic partnerships with global pharmaceutical companies, Laurus Labs has established itself as one of India’s fastest-growing pharmaceutical manufacturers and a trusted global healthcare partner.
NSE: LAURUSLABS | BSE: 540222
Hyderabad, Telangana, India
~8,000 employees
